This study will assess how two different ablation strategies, using two different ablation catheters during catheter ablation for paroxysmal atrial fibrillation, affect the temperature of the esophagus during ablation, and the risk of injury to the esophagus.
This is a prospective randomized controlled trial, studying patients undergoing ablation involving pulmonary vein isolation for paroxysmal atrial fibrillation. Patients will be assigned to undergo conventional high-power short-duration ablation or temperature-controlled very-high-power short-duration ablation, and esophageal outcomes including temperature changes during ablation and esophageal injury as assessed by post-procedure capsule endoscopy will be compared between the groups. The hypothesis is that very-high-power short-duration ablation will lead to lower rises in esophageal temperature and lower rates of esophageal findings during capsule endoscopy.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
30
QDOT Micro ablation catheter
ST SF ablation catheter
Cedars-Sinai Smidt Heart Institute
Los Angeles, California, United States
RECRUITINGMaximal change in esophageal temperature during posterior wall isolation.
Time frame: During ablation procedure.
Presence of esophageal thermal injury seen on post-procedure capsule endoscopy.
Time frame: 2-4 days after ablation procedure.
Presence of procedural complications.
Time frame: During and immediately following ablation procedure.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.